Chronic myeloid leukemia (CML) is a blood cancer that affects about 200,000 new people each year. This difficult-to-treat disease starts …
Study: Leukemia Treatment Tasigna May Treat Parkinson’s, Alzheimer’s
A June 2016 study looked at controversial leukemia treatment Tasigna (nilotinib) to measure its effect on Parkinson’s symptoms. According to …
Low T Lawsuits Reveal a Massive Market—and Irreversible Adverse Effects
Companies market testosterone products to young men for physical enhancement and older men hoping to stave off aging. Ranging in …
We Translate Tasigna’s QT Prolongation Warning Into Plain English
The U.S. Food and Drug Administration approved leukemia drug Tasigna (generic name: nilotinib) in 2007. In 2015, however, the FDA …